Form 4 for VCYT VERACYTE, INC.
Accepted 2024-12-06 00:00:00 ET · period of report 2024-12-04 · accession 0001384101-24-000186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-06 | 2024-12-04 | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | S - Sale | $44.09 | -3,934 | 82.4K | -5% | -$173.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-04 | S | D | 3,934 | $44.09 | 82,414 | D | — | — | (F2) Represents weighted average sales price. Sale prices for the transactions range from $43.60 to $44.46. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |